Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study

Fig. 2

Kaplan–Meier survival estimates. a, b Demonstrate the short-term (follow-up, one year, N = 2482) association between beta-blockers and all-cause mortality/recurrent myocardial infarction. A log-rank test was used. The results suggest that there was no statistically significant association between discharge prescription of beta-blockers and risk of all-cause mortality and a statistically significant association between discharge prescription of beta-blockers and reduced risk of recurrent myocardial infarction. c, d Demonstrate the long-term (median follow-up, 3.75 years, N = 2519) association between beta-blockers and all-cause mortality/recurrent myocardial infarction. A log-rank test was used. The results suggest that there was no statistically significant association between discharge prescription of beta-blockers and risk of all-cause mortality/ recurrent myocardial infarction. IPTW correction: based on propensity score with inverse probability treatment weighting (IPTW), adjusted for factors as described in Table 2

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us